While tobacco and alcohol are known to increase the risk of head and neck cancer, new research has found the amount of coffee ...

The biotherapeutics company said the treatment, LYT-200, is being evaluated in two ongoing clinical trials. It was previously granted orphan drug designation for the treatment of acute myeloid ...

The Jimmy Carter drug introduced the world to cancer immunotherapy, a treatment that differs from chemotherapy. Carter was ...

An analysis of global studies suggests that consuming coffee and tea may reduce the risk of head and neck cancers.

Biotherapeutics company PureTech Health plc (PRTC) announced Thursday that the U.S. Food and Drug Administration (FDA) has granted ...

PAX-1 is under clinical development by Komipharm International and currently in Phase I for Head And Neck Cancer.

GORTEC, known as Head and Neck Radiation Oncology Group, today announced that the randomized Phase 3 NIVOPOSTOP GORTEC ...

Obsessed with chai Or Coffee Well its your day to be happy Recent research suggests that this daily ritual might be lowering ...

CTX-471 is under clinical development by Compass Therapeutics and currently in Phase I for Head And Neck Cancer.

Drinking coffee and tea could lower the risk of some head and neck cancers, but giving up alcohol and tobacco could have a ...

LYT-200 is currently being evaluated in two Phase 1/2 trials for the potential treatment of AML/MDS and head and neck cancers PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company” ...